...
首页> 外文期刊>BMC Nephrology >Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis
【24h】

Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis

机译:与连续肾脏替代疗法(CRRT)中滤器寿命相关的非抗凝因子:系统评价和荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Optimising filter life and performance efficiency in continuous renal replacement therapy has been a focus of considerable recent research. Larger high quality studies have predominantly focussed on optimal anticoagulation however CRRT is complex and filter life is also affected by vascular access, circuit and management factors. We performed a systematic search of the literature to identify and quantify the effect of vascular access, circuit and patient factors that affect filter life and presented the results as a meta-analysis. Methods A systematic review and meta-analysis was performed by searching Pubmed (MEDLINE) and Ovid EMBASE libraries from inception to 29th February 2016 for all studies with a comparator or independent variable relating to CRRT circuits and reporting filter life. Included studies documented filter life in hours with a comparator other than anti-coagulation intervention. All studies comparing anticoagulation interventions were searched for regression or hazard models pertaining to other sources of variation in filter life. Results Eight hundred nineteen s were identified of which 364 were selected for full text analysis. 24 presented data on patient modifiers of circuit life, 14 on vascular access modifiers and 34 on circuit related factors. Risk of bias was high and findings are hypothesis generating. Ranking of vascular access site by filter longevity favours: tunnelled semi-permanent catheters, femoral, internal jugular and subclavian last. There is inconsistency in the difference reported between femoral and jugular catheters. Amongst published literature, modality of CRRT consistently favoured continuous veno-venous haemodiafiltration (CVVHD-F) with an associated 44% lower failure rate compared to CVVH. There was a trend favouring higher blood flow rates. There is insufficient data to determine advantages of haemofilter membranes. Patient factors associated with a statistically significant worsening of filter life included mechanical ventilation, elevated SOFA or LOD score, elevations in ionized calcium, elevated platelet count, red cell transfusion, platelet factor 4 (PF-4) antibodies, and elevated fibrinogen. Majority of studies are observational or report circuit factors in sub-analysis. Risk of bias is high and findings require targeted investigations to confirm. Conclusion The interaction of patient, pathology, anticoagulation, vascular access, circuit and staff factors contribute to CRRT filter life. There remains an ambiguity from published data as to which site and side should be the first choice for vascular access placement and what interaction this has with patient factors and timing. Early consideration of tunnelled semi-permanent access may provide optimal filter life if longer periods of CRRT are anticipated. There remains an absence of robust evidence outside of anti-coagulation strategies despite over 20?years of therapy delivery however trends favour CVVHD-F over CVVH.
机译:背景技术在连续性肾脏替代治疗中优化滤器寿命和性能效率已成为近期大量研究的重点。较大的高质量研究主要集中在最佳抗凝治疗上,但是CRRT很复杂,并且滤器的寿命也受血管通路,回路和管理因素的影响。我们对文献进行了系统的搜索,以识别和量化影响过滤器寿命的血管通路,回路和患者因素的影响,并将结果作为荟萃分析呈现。方法通过对Pubmed(MEDLINE)和Ovid EMBASE库从开始到2016年2月29日进行搜索,对所有具有CRRT回路和报告过滤器的比较器或自变量进行研究,以进行系统的回顾和荟萃分析生活。包括在内的研究记录了使用抗凝剂以外的其他比较器在数小时内的过滤器寿命。搜索所有比较抗凝干预措施的研究,以寻找与过滤器寿命变化的其他来源有关的回归模型或危险模型。结果鉴定出819个样本,其中364个被选择用于全文分析。 24位患者提供了有关回路寿命的患者调节因素的数据,14位患者提供了血管通路调节因素的数据,34位患者提供了有关回路相关因素的数据。偏见的风险很高,并且发现会产生假设。通过过滤器寿命的长短对血管进入部位的排名:隧道式半永久性导管,股骨,颈内和锁骨下动脉。股动脉导管和颈动脉导管之间报道的差异不一致。在已发表的文献中,CRRT的模式始终支持连续静脉血液透析滤过(CVVHD-F),与CVVH相比,其失败率降低了44%。趋势是有利于更高的血液流速。没有足够的数据来确定血液滤膜的优势。与过滤器寿命的统计学显着恶化相关的患者因素包括机械通气,SOFA或LOD评分升高,离子钙升高,血小板计数升高,红细胞输注,血小板因子4(PF-4)抗体和纤维蛋白原升高。大多数研究是在子分析中观察或报告回路因素。偏见的风险很高,调查结果需要有针对性的调查以确认。结论患者,病理,抗凝,血管通路,回路和人员因素之间的相互作用有助于CRRT过滤器的使用寿命。从公开的数据来看,关于哪个部位和哪一侧应该是血管通路放置的首选,以及这与患者因素和时机之间有什么相互作用,尚不明确。如果可以预期更长的CRRT时间,则尽早考虑使用隧道式半永久性通道可以提供最佳的过滤器寿命。尽管已有超过20年的治疗时间,但在抗凝治疗策略之外仍缺乏有力的证据,但趋势是CVVHD-F优于CVVH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号